2Solomon RJ, Mehran R, Natarajan MK, et al. Gontrast-mduced nephropathy and long-term adverse events:cause and effect [ J ]. Clin J Am Soc Nephro1,2009,4 (7) : 1162-1169.
3Dangas G, Iakovou I, Nikolsky E, et al. Contrast-induced nephropa- thy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamie variables[ J]. Am J Cardiol,2005, 95(1) :13-19.
4Ridker PM, Danielson E, Fonscca FA, et al. Rosuvastatin to pmvent vascular events in men and women with elevated C-reactive prorein [J]. N Engl J Med,2008,359(21 ) :2195-2207.
5Gonzales DA, Nonwoahy KJ, Kern SJ, et al. A meta-analysis of N- acetylcysteine in contrast-induced nepbrotoxicity:unsupervised clus- tering to resolve heterogeneity [ J ]. BMC Med,2007,14 ( 5 ) :32-40.
6Marenzi G, Lauri G, Assanelli E, et al. Contrast induced nephropathy inpatients undergoing primary angioplasty for acute myocardial infarction [ J ]. Amcoll cardio1,2004,44 (9) : 1780-1785.
7Van Praet JT, De Vriese AS. Prevention of contrast-induced hep- hropathy a critical review [ J ]. Curt Opin Nephrol Hypertens, 2007, 16(4) :336-347.
